Naftzger J. Christopher - Insider Non-Derivative Transactions at Arbutus Biopharma Corp (ABUS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 14, 2025, Naftzger J. Christopher's relationship to Arbutus Biopharma Corp (ABUS) is Officer (General Counsel and CCO), and currently has 140,544 shares of Common Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABUS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Naftzger J. Christopher - Insider Non-Derivative Transactions of ABUS Common Shares

Naftzger J. Christopher - Insider Non-Derivative Transactions at ABUS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 15, 2025	Acquisition -- (Common Shares)	54300	0	140544
Feb 5, 2025	Sell -- (Common Shares)	11333	3.28	86244
Feb 2, 2024	Acquisition -- (Common Shares)	95100	0	95100